2-(2,6-Dioxopiperidin-3-yl)-4-fluoroisoindoline-1,3-dione>98.0%(HPLC)(T)5g

2-Cyano-N-ethylacetamide, 97.0%, 10g

(R)-3-Amino-1-N-Cbz-piperidine, 97.0%, 5g

1-(3-Methoxy-benzyl)-[1,4]diazepane, 1g

4-Chloro-5-(trifluoromethyl)pyrimidin-2-amine, 95.0%, 250mg

2-Bromo-4-methoxyaniline, 95.0%, 1g

tert-Butyl 3-(Bromomethyl)azetidine-1-carboxylate>98.0%(GC)5g

1-(tert-Butyl)-2-nitrobenzene, 95.0%, 25g

3-Methoxy-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzonitrile, 95+%, 1g

Dipropylene glycol monopropyl ether, min 98%, for synthesis, 2.5L, plastic packaging.

2-(Naphthalen-2-yl)acetic acid, 98.0%, 10g

2,4-DICHLORO-7H-PYRROLO[2,3-D]PYRIMIDINE-6-CARBOXYLIC ACID, 95.0%, 10g

2-Hydroxy-9H-fluoren-9-one, 95.0%, 1g